Efficacy of a cannabis-based oromucosal spray in managing peripheral neuropathic pain
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatmentEur J Pain. 2014 Aug;18(7):999-1012. doi: 10.1002/j.1532-2149.2013.00445.x
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
303 patients with peripheral neuropathic pain (PNP) were randomized to either Nabiximols or placebo for 14 weeks. Significant improvements in pain, quality of sleep and Subject Global Impression of Change (SGIC) were found in patients that received Nabiximols compared to those that received placebo. No patients experienced severe treatment-related adverse events in the Sativex group versus one in ...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue